Education
About Us
Working with TipRanks
Follow Us
Alphaton Capital Corp. (ATON)
:ATON
ATON Stock Chart & Stats
$5.84
--
Market closed
$5.84
--
Day’s Range― - ―
52-Week Range$2.95 - $15.82
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.64M
Market Cap
$32.57M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.67M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.99
Next Earnings
Dec 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,349,197
10 Day Avg. Volume409,443
30 Day Avg. Volume1,642,630
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-88.97
Price to Sales (P/S)0.00
P/FCF Ratio-2.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AlphaTON Capital News
ATON FAQ
What was Alphaton Capital Corp.’s price range in the past 12 months?
Alphaton Capital Corp. lowest stock price was $2.95 and its highest was $15.82 in the past 12 months.
What is Alphaton Capital Corp.’s market cap?
Alphaton Capital Corp.’s market cap is $32.57M.
When is Alphaton Capital Corp.’s upcoming earnings report date?
Alphaton Capital Corp.’s upcoming earnings report date is Dec 02, 2025 which is in 34 days.
How were Alphaton Capital Corp.’s earnings last quarter?
Currently, no data Available
Is Alphaton Capital Corp. overvalued?
According to Wall Street analysts Alphaton Capital Corp.’s price is currently Overvalued.
Does Alphaton Capital Corp. pay dividends?
Alphaton Capital Corp. does not currently pay dividends.
What is Alphaton Capital Corp.’s EPS estimate?
Alphaton Capital Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alphaton Capital Corp. have?
Alphaton Capital Corp. has 6,349,197 shares outstanding.
What happened to Alphaton Capital Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Alphaton Capital Corp.?
Currently, no hedge funds are holding shares in ATON
AlphaTON Capital Stock Smart Score
Company Description
Alphaton Capital Corp.
Portage Biotech Inc. (PRTG) is a biotechnology company focused on developing innovative immuno-oncology therapies. The company operates primarily in the health care sector, specifically targeting the treatment of cancer through its proprietary platform technologies and a robust pipeline of novel therapeutics. Portage Biotech aims to enhance the body's immune response to fight cancer, offering potential breakthroughs in cancer treatment.
Technical Analysis
Can-Fite BioPharma
―
Phio Pharmaceuticals
―
Cellectar Biosciences
―
MetaVia
―
Bolt Biotherapeutics
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.85% Other Institutional Investors
99.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---